+ND Capital

3B Future Health Ventures

3xP Global

4BIO Capital

AATec Medical GmbH

AbbVie

abcDNA GmbH

ABYOLO AG

Accequa AB

Access2Health Consulting

AdBio Partners

Addex Therapeutics Ltd.

Adoram Therapeutics SA

Advanced BioDesign

Advestra AG

aescuvest GmbH

AFK & Partners LLC

Ageronix SA

Agile Capital Markets

AIPTO TechBio GmbH

AKIGAI AS

Akribion Therapeutics GmbH

Alder Therapeutics AB

AlgenScribe SAS

Aliath Bioventures

Allele Capital Partners

ALSA Ventures

Alzheimer's Disease | Remember Drug

Amarna Therapeutics

AMR Action Fund GP GmbH

Anaveon AG

Andera Partners SA

Angelini Ventures S.p.A.

ANNIMO Health EDC AG

Antisoma Venture Capital Fund S.A

Apogenix i.L.

Apollo Health Ventures

ArchiMed

Ardena

Ariceum Therapeutics GmbH

Ariya Bio c/o ETH Zürich

ARVE Capital GmbH

Asahi Kasei Europe GmbH

Asahi Kasei Pharma Corporation

Asahi Kasei Ventures

Asklepios Advisors

Astellas Pharma Europe Ltd.

AstraZeneca

Atamyo Therapeutics SAS

Atopia Therapeutics

Aukera Therapeutics GmbH

Aurealis Therapeutics AG

AurorA Science Srl

AVANTECA Partners AG

Avata Biosciences

Avego Bioscience Capital

Awen GmbH

AXA Investment Managers

BaseLaunch

BD as a Service

Bellevue Asset Management AG

Bergaud & Partners

Bergmann zur Hausen & Cie. GmbH

BERNINA BioInvest Ltd.

Bio Med Gene Ventures

BioGeneration Ventures

BioMedPartners AG

BiomedVC AG

biomindz Standortentwicklungsgesellschaft Mainz mbH

Bioqube Ventures

BIOSTART Consulting GmbH

Biotx.ai

BioValley Basel

Biovance Capital

Biovision Ventures

BiPER Therapeutics

Bird & Bird LLP

BlackRock Advisors

Bloom Science

Bloomberg Intelligence

BlueSky Immunotherapies GmbH

Boehringer Ingelheim International GmbH

Boehringer Ingelheim Venture Fund GmbH

BOLD Longevity Growth Fund

Bootstrap Europe

Bradley Woods & Co. Ltd.

Brenus Pharma

Breslin AG

British Patient Capital

BROTHERS & Partners Europe

Business Angels Switzerland

Calida Therapeutics SAS

Calliditas Therapeutics AB

Camallergy

Canton of Basel-Stadt

Cantoni Therapeutics BV

Carma Fund

Carmouflage

CaSRevolution S.r.l.

Catalpa Ventures S.à r.l.

CDP Venture Capital SGR S.p.A.

CDP Venture Capital SGR ​S.p.A.

Cellestia Biotech AG

cellvie Inc.

Changchun GeneScience Pharmaceutical Co.

Charles Consultants (Life Sciences) Limited

Chugai Venture Fund

CIS BIOPHARMA AG

Claris Ventures

Clave Capital

CMS Medical Venture Investment Ltd.

CNS Pharmaceuticals

Cohesion Bureau

Convergence Partners AG

Corden Pharma International Switzerland LLC

Coulter Partners

Cukierman & Co. Life Sciences

Cullgen Inc.

Cumulus Oncology

Curaxon AG

Cureteq AG

Curie.Bio

Danube BioVentures

DeBere Capital Partners

Debiopharm International SA

Delin Ventures Ltd.

Digital Networks PLC

Dimericon Therapeutics AG

Dinette/Synapse Vision

Droia Ventures NV

éclateral Ltd.

Eczacibasi Pharmaceutical and Industrial Investment Co.

Edison Group

EIT Health e.V.

eleva GmbH

Eli Lilly and Company

Elpiscience Biopharmaceuticals Co. Ltd.

Endeavor Life Science Venture Fund

ENV Ventures

EQT Life Sciences

European Investment Bank

European Investment Fund

Evariste

Evernow Publishing Ltd

EvlaBio AG

EVORA Biosciences

Exazyme GmbH

ExperTrials

F. Hoffmann-La Roche AG

Facultas Partners

FastVentures B.V.

FimmCyte AG

Finanz und Wirtschaft / Tamedia

Flagship Pioneering

FluoSphera SA

Forbion

Forty51 Ventures

FoRx Therapeutics AG

Fraser Partners

Fraunhofer IZI (Institute for Cell Therapy and Immunology)

FreeMind Group

Fund+

Fusix Biotech GmbH

G4 FRIENDS LTD.

GALSER SA

Gan & Lee Pharmaceuticals

Generation Fund Life Sciences Fund I

Genius Search GmbH & Co. KG

GenSearch Switzerland GmbH

German Accelerator Life Sciences

GIBF

Gilde Healthcare Partners B.V.

Gimv

GL Capital

GOLDTRACK Ventures GmbH

Grabulovski Consulting Services GmbH

GrowthCube Partners LLC

GSK

Gubra A/S

H Tree Capital

H. Lundbeck A/S

H.C. Wainwright & Co.

Hadean Ventures

Harmonic Discovery Inc.

HBM Partners AG

Heal Capital

Health Innovation Capital

HealthCap

Hephaistos Pharma

Heran Partners BV

Herantis Pharma Plc

High-Tech Gründerfonds

Hitachi Ventures GmbH

IAG Italian Angels for Growth

IAMA Therapeutics S.r.l.

ICF Consult Switzerland

ILC Therapeutics Ltd

Immunyx Pharma

Indaco Venture Partners SGR S.p.A.

Index Capital

InnoGrant Advisors KLG

Innovestor Life Science Ltd.

INOGROUP GmbH

Insilico Medicine

Intercontinental Capital

International Institute for Management Development

Inveready Asset Management

InvestHK

iOnctura SA

IPF Partners

IQVIA

Jeito Capital

JFG Life Sciences Foundation

Johnson & Johnson Innovation LLC

JPMorgan Chase & Co.

Karista

Kerna Ventures

King Bioventures

Kurma Partners

L.E.K. Consulting

Ladenburg Thalmann & Co. Inc.

Landmark Angels

Landmark BioVentures AG

Laverock Therapeutics Ltd.

Leads To Development

LifeCare Partners GmbH

LIfT BioSciences Ltd.

Lipocyte BioMed GmbH

LMU Munich

LSA Ventures

LSV Capital Partners

LuSeed Vascular

Lynx Financial Hong Kong Ltd.

Lyonbiopôle

M Ventures

M2Care

Mabylon AG

MEDiSTRAVA Consulting

Memo Therapeutics AG

Merck KGaA

Mergermarket

MetrioPharm AG

MexBrain

Mid Atlantic Bio Angels

MIG Capital

Modiblast Pharma GmbH

MSQ Ventures

MUVON Therapeutics AG

MVM Partners LLP

NanoCell Therapeutics

Nasdaq

NatIgGs GmbH

Neurevo GmbH

New Science Fund

Nextech Invest Ltd.

NG Bio

NH TherAguix SAS

Nouscom AG

NovAliX SAS

NovaPump GmbH

Novartis AG

Novartis Venture Fund

Novo Holdings A/S

Novo Nordisk A/S

NRW.Venture

Nxera Pharma

NXI Therapeutics AG

NxR Biotechnologies GmbH

Octopus Ventures

Olgram SAS

Omega Funds

Oncode Oncology Bridge Fund

Oncosema

Oncoteq AG

One Up Consulting

Onena Medicines AG

Onward Therapeutics SA

OrbiMed Advisors LLC

Orixha

Oryzon Genomics

Ousia Pharma ApS

Palleos Healthcare GmbH

Panakès Partners SGR SpA

Partex N.V.

Paul Larue Business Development Consulting

PDC*line Pharma SA

Peregrine Ventures

Perseo Pharma AG

Persica Pharmaceuticals Ltd.

Pfizer

Pharmaron UK Ltd

Philos & Partners Ltd

Pictet & Cie

Pilatus Biosciences SA

Playground Global

Pleco Therapeutics BV

PMV NV

Preclina Inc.

Prevatex Pty Ltd

PROSION GmbH

PulseSight Therapeutics

Pureos Bioventures

Qiming Venture Partners

Quadrille Capital

Quant Biomarkers AG

Reconnect Labs AG

Redalpine Venture Partners AG

RNATICS GmbH

Roca Therapeutics

Roche Diagnostics

Ropes & Gray LLP

Rosetta Capital Ltd.

Rosetta Omics

RV Invest GmbH

Salvina Therapeutics Inc.

Sand Hill Angels

Scendea Ltd.

SciRhom GmbH

Scius Communications

Scobag Private Bank AG

Secarna Pharmaceuticals GmbH & Co. KG

Second Thought

Seekyo Therapeutics

Selvita S.A.

Seroba Life Sciences

Seventure Partners

Sixty Degree Capital

Skymab Biotherapeutics

Sofinnova Partners

Sound Bioventures Management AB

Staatz BD & Strategy

STALICLA SA

steerBIO GmbH

Stifel

Stimunity SAS

Sulfateq BV

Sunstone Life Science Ventures

Superlab Suisse AG

SurgiMab S.A.S.

Suterscience GmbH

Swiift Imaging SAS

Swiss Biotech Association

Symeres B.V.

Taiho Ventures

TargImmune Therapeutics AG

Telomere Therapeutics

Test

Thabor Therapeutics

THERAtRAME S.A.

Thermosome GmbH

Tigermed

TME Pharma

TOLREMO Therapeutics AG

TransCure bioServices SAS

TruVenturo GmbH

TVM Capital Life Science

UBS AG

UCEA Family Office

Umlaut.bio GmbH

Università Svizzera Italiana

University Hospital of Zürich

University of Zurich

Urania Therapeutics

V-Bio Ventures BV

Valor Management

Venture Valuation AG

Versant Ventures

Vesalius Biocapital IV Partners SàrL

VI Partners AG

VIB

Viopas Venture Consulting

Vogel BioC

VUS Diagnostics

WBB Securities

Wellington Partners

Womble Bond Dickinson

WuXi STA

XGEN Venture SGR S.p.A.

XOventure GmbH

YAYA Capital

Ysios Capital

Zinc VC